Chia Tai Enterprises International stock analysis
Want to see HK:3839 full AI Analyst Report?
Chia Tai Enterprises International (3839) Stock Price & Analysis
3839 Stock Chart & Stats
- Day’s Range
- HKD 7.50 - HKD 7.50
- 52-Week Range
- HKD 5.50 - HKD 9.89
- Previous Close
- HKD 7.50
- Volume
- N/A
- Average Volume (3M)
- 46.26K
- Market Cap
- HKD 1.90B
- Enterprise Value
- HKD 2.61B
- Total Cash (Recent Filing)
- HKD 37.25M
- Total Debt (Recent Filing)
- HKD 75.56M
- Price to Earnings (P/E)
- 9.9
- Beta
- 0.97
- Next Earnings
- Feb 25, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Revenue Rebound
The sharp 2025 revenue rebound indicates stronger business activity and improved scale after a weaker prior year. If the higher revenue base can be maintained, it may support operating leverage, broaden distribution economics, and provide greater capacity to fund products and agribusiness opportunities.
Improved Profitability
Improved operating and net margins show that the recent revenue recovery translated into better earnings rather than growth without profitability. Sustained margin improvement would strengthen internal funding, improve returns on invested capital, and make the business more resilient across livestock and animal-health cycles.
Conservative Leverage And Cash Recovery
Lower leverage gives the company greater financial flexibility and reduces the burden of debt service during weaker operating periods. The return to positive free cash flow also indicates improved funding quality, allowing more growth investment or balance-sheet support without relying as heavily on external capital.
Bears Say
Gross Margin Compression
The decline in gross margin indicates that a smaller portion of sales is converting into gross profit than in earlier years. Persistent pricing or cost pressure could limit the durability of recent operating improvements, reduce reinvestment capacity, and leave earnings more exposed to changes in product mix or demand.
Uneven Cash Generation
Historically inconsistent cash generation makes reported profitability less dependable as a source of funding. Even with positive free cash flow in 2025, recurring working-capital or reinvestment demands could again absorb earnings, constrain liquidity, and reduce flexibility to expand distribution or product capabilities.
Earnings Volatility
The history of losses and changing margins shows that earnings have not yet demonstrated consistent stability across periods. This volatility raises execution risk because a weaker livestock cycle, less favorable product mix, or renewed cost pressure could materially reduce returns and slow balance-sheet strengthening.
Chia Tai Enterprises International News
3839 FAQ
What was Chia Tai Enterprises International’s price range in the past 12 months?
What is Chia Tai Enterprises International’s market cap?
When is Chia Tai Enterprises International’s upcoming earnings report date?
How were Chia Tai Enterprises International’s earnings last quarter?
Is Chia Tai Enterprises International overvalued?
Does Chia Tai Enterprises International pay dividends?
What is Chia Tai Enterprises International’s EPS estimate?
How many shares outstanding does Chia Tai Enterprises International have?
What happened to Chia Tai Enterprises International’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Chia Tai Enterprises International?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Chia Tai Enterprises International
CPBIO Holding Company Limited produces and distributes chlortetracycline (CTC) and related goods. Its extensive international reach covers Mainland China, the Asia Pacific region, the Americas, and Europe. The company's operations are divided into two distinct divisions: Biochemical and Industrial. The Biochemical division focuses on the manufacturing and supply of CTC premix and CTC hydrochloride products. These are employed as feed supplements to encourage livestock growth, prevent or cure animal illnesses, and improve feed conversion, sold under the brands Shihao and Citifac. Conversely, the Industrial segment handles the sales, rental, and maintenance of heavy construction machinery, encompassing items such as excavators, power generators, bulldozers, compactors, and their spare parts. This division also fabricates and markets carburetors and other automotive components for various automobile and motorcycle manufacturers. Founded in 1987, the company maintains its headquarters in Central, Hong Kong, and functions as a subsidiary of Charoen Pokphand Foods Public Company Limited.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Chawalit Na Muangtoun
- Employees
- 1,000
- Website
- www.cp-bio.com
- Address
- HK
Chia Tai Enterprises International (3839) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 3 | 5 | 14 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 0 | 0 | 12 |









